These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 30123183)
1. Upregulation of Oxytocin Receptor in the Hyperplastic Prostate. Li Z; Xiao H; Wang K; Zheng Y; Chen P; Wang X; DiSanto ME; Zhang X Front Endocrinol (Lausanne); 2018; 9():403. PubMed ID: 30123183 [No Abstract] [Full Text] [Related]
2. Upregulation of Phosphodiesterase type 5 in the Hyperplastic Prostate. Zhang W; Zang N; Jiang Y; Chen P; Wang X; Zhang X Sci Rep; 2015 Dec; 5():17888. PubMed ID: 26657792 [TBL] [Abstract][Full Text] [Related]
3. Colocalization of androgen binding protein, oxytocin receptor, caveolin 1 and proliferation marker p21 in benign prostate hyperplasia. Sendemir E; Herbert Z; Sivukhina E; Zermann DH; Arnold R; Jirikowski GF Anat Histol Embryol; 2008 Oct; 37(5):325-31. PubMed ID: 18312604 [TBL] [Abstract][Full Text] [Related]
4. Upregulated Interleukin 21 Receptor Enhances Proliferation and Epithelial-Mesenchymal Transition Process in Benign Prostatic Hyperplasia. Xu D; Chen P; Xiao H; Wang X; DiSanto ME; Zhang X Front Endocrinol (Lausanne); 2019; 10():4. PubMed ID: 30728806 [No Abstract] [Full Text] [Related]
5. Evidence of oxytocin/oxytocin receptor interplay in human prostate gland and carcinomas. Cassoni P; Marrocco T; Sapino A; Allia E; Bussolati G Int J Oncol; 2004 Oct; 25(4):899-904. PubMed ID: 15375538 [TBL] [Abstract][Full Text] [Related]
6. Changes in the expression and functional activities of Myosin II isoforms in human hyperplastic prostate. He W; Wang X; Zhan D; Li M; Wang Q; Liu J; Liu D; Fu X; Qian Q; Li Y; Chen P; Zeng G; Wang X; DiSanto ME; Zhang X Clin Sci (Lond); 2021 Jan; 135(1):167-183. PubMed ID: 33393635 [TBL] [Abstract][Full Text] [Related]
7. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues. Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354 [TBL] [Abstract][Full Text] [Related]
8. Differential expression of androgen, estrogen, and progesterone receptors in benign prostatic hyperplasia. Song L; Shen W; Zhang H; Wang Q; Wang Y; Zhou Z Bosn J Basic Med Sci; 2016 Jul; 16(3):201-8. PubMed ID: 27294569 [TBL] [Abstract][Full Text] [Related]
9. Glutathione Peroxidase 3 induced mitochondria-mediated apoptosis via AMPK /ERK1/2 pathway and resisted autophagy-related ferroptosis via AMPK/mTOR pathway in hyperplastic prostate. Li Y; Zhou Y; Liu D; Wang Z; Qiu J; Zhang J; Chen P; Zeng G; Guo Y; Wang X; DiSanto ME; Zhang X J Transl Med; 2023 Aug; 21(1):575. PubMed ID: 37633909 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-18 may lead to benign prostatic hyperplasia via thrombospondin-1 production in prostatic smooth muscle cells. Hamakawa T; Sasaki S; Shibata Y; Imura M; Kubota Y; Kojima Y; Kohri K Prostate; 2014 May; 74(6):590-601. PubMed ID: 24615654 [TBL] [Abstract][Full Text] [Related]
11. Testosterone regulates myosin II isoforms expression and functional activity in the rat prostate. Chen P; Xiao H; Huang W; Xu DQ; Guo YM; Wang X; Wang XH; DiSanto ME; Zhang XH Prostate; 2018 Dec; 78(16):1283-1298. PubMed ID: 30073674 [TBL] [Abstract][Full Text] [Related]
12. Regulation of proliferation and differentiation of prostatic stromal cells by oestradiol through prostatic epithelial cells in a paracrine manner. Wu Q; Shi J; Chen L; Wang CY; Park I; Lee C; Zhang J BJU Int; 2008 Feb; 101(4):497-502. PubMed ID: 18190643 [TBL] [Abstract][Full Text] [Related]
13. Role of the stromal microenvironment in carcinogenesis of the prostate. Cunha GR; Hayward SW; Wang YZ; Ricke WA Int J Cancer; 2003 Oct; 107(1):1-10. PubMed ID: 12925950 [TBL] [Abstract][Full Text] [Related]
14. FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia. Polnaszek N; Kwabi-Addo B; Wang J; Ittmann M Prostate; 2004 Jun; 60(1):18-24. PubMed ID: 15129425 [TBL] [Abstract][Full Text] [Related]
15. Proliferation of Prostate Stromal Cell Induced by Benign Prostatic Hyperplasia Epithelial Cell Stimulated With Trichomonas vaginalis via Crosstalk With Mast Cell. Kim JH; Kim SS; Han IH; Sim S; Ahn MH; Ryu JS Prostate; 2016 Nov; 76(15):1431-44. PubMed ID: 27325623 [TBL] [Abstract][Full Text] [Related]
16. Changes in receptor location affect the ability of oxytocin to stimulate proliferative growth in prostate epithelial cells. Gould ML; Nicholson HD Reprod Fertil Dev; 2019 May; 31(6):1166-1179. PubMed ID: 31034785 [TBL] [Abstract][Full Text] [Related]
17. Expression and functional activity of myosin II in hyperplastic prostates of varying volumes. Liu J; Liu D; Zhang J; He W; Guo Y; Li Y; Chen P; DiSanto ME; Zhang X Cell Signal; 2023 Jun; 106():110658. PubMed ID: 36935086 [TBL] [Abstract][Full Text] [Related]
18. The effect of oxytocin on cell proliferation in the human prostate is modulated by gonadal steroids: implications for benign prostatic hyperplasia and carcinoma of the prostate. Whittington K; Connors B; King K; Assinder S; Hogarth K; Nicholson H Prostate; 2007 Jul; 67(10):1132-42. PubMed ID: 17492653 [TBL] [Abstract][Full Text] [Related]
19. Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate. Krieg M; Nass R; Tunn S J Clin Endocrinol Metab; 1993 Aug; 77(2):375-81. PubMed ID: 7688377 [TBL] [Abstract][Full Text] [Related]
20. Role of stroma in carcinogenesis of the prostate. Cunha GR; Hayward SW; Wang YZ Differentiation; 2002 Dec; 70(9-10):473-85. PubMed ID: 12492490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]